News & Views | Published:

CNS Infections

A new herpes zoster subunit vaccine for older adults

Nature Reviews Neurology volume 12, pages 682683 (2016) | Download Citation

A randomized placebo-controlled phase III trial of adjuvanted herpes zoster subunit vaccine has shown a substantial improvement in vaccine efficacy in adults aged ≥70 years compared with the currently used, live attenuated vaccine. The finding has profound implications for reducing illness burden, although the duration of vaccine protection needs further evaluation.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Efficacy of herpes zoster subunit vaccine in adults 70 years of age or older. N. Engl. J. Med. 375, 1019–1032 (2016).

  2. 2.

    et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N. Engl. J. Med. 372, 2087–2096 (2015).

  3. 3.

    & Review of the persistence of herpes zoster vaccine efficacy in clinical trials. Clin. Ther. 37, 2388–2397 (2015).

  4. 4.

    et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 352, 2271–2284 (2005).

  5. 5.

    et al. Efficacy, safety and tolerability of herpes zoster vaccine in persons aged 50–59 years. Clin. Infect. Dis. 54, 922–928 (2012).

  6. 6.

    Immune senescence and vaccines to prevent herpes zoster in older persons. Curr. Opin. Immunol. 24, 494–500 (2012).

  7. 7.

    , & The role of the T cell in age-related inflammation. Age (Dordr.) 35, 563–572 (2013).

  8. 8.

    The nature of herpes zoster: a long-term study and a new hypothesis. Proc. R. Soc. Med. 58, 9–20 (1965).

  9. 9.

    et al. Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: a cohort study. Neurology 87, 94–102 (2016).

  10. 10.

    , , , & The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013. J. Infect. 73, 241–253 (2016).

Download references

Author information

Affiliations

  1. Charlotte Warren-Gash is at the Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.

    • Charlotte Warren-Gash
  2. Judith Breuer is at the Division of Infection & Immunity, University College London, 90 Gower Street, London, WC1E 6BT, UK.

    • Judith Breuer

Authors

  1. Search for Charlotte Warren-Gash in:

  2. Search for Judith Breuer in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Judith Breuer.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrneurol.2016.168

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing